CDKN2A and colonic neoplasm: Administration of quercetin (1 μM) alone inhibited growth of human RKO colon cancer cells and restored p16INK4α gene expression in a dose-dependent manner, which was associated with a significant reversal of hypermethylation of the p16INK4α promoter (109).